Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is an excellent development. It will emphasize the need for the brokers to have an accounting. Raise your hand if you bought shares from VERT. You brokerage is not going to have the shares to back your cert at DTC. When they realize that - only then will we see the squeeze.
If all the longs stick together on this one they are going to pay dearly for their transgressions. Once I brokerage does a buy-in the rest will flock in. It doesnt take much to move the price.
Anyone want to see this short fry? Where is hongkongkingkong anyhow. Hes pretty quiet.
More evidence of shorting. If there is supply on the offer like right now 2000 shares ETRF 2.56. VERT moves out of the way and lets the market maker do their selling and they are .01 above in price at 2.57. They are perma offer.
you sir a blind. The evidence is on level 2. you will see a big offer smack on lets say a .10 spread an the offer gets smacked for 5000 shares and then the VERT goes offer for 100 shares over the bid so the next print looks down. Its done time and time again during the day. All the offer smacks are low offered o the very next tick and it ALL VERT.
Buyin hasnt happened yet. If the brokerages do it they still have time until Friday. They can do CASH settlement. Shorts are going to exploit that articles flaws of setting a line in the sand of 26 Sept. They can buy up until friday that is my theory on what is happening but.... if one firm starts covering. It only takes one this will fly.
Agreed that there is a large value story. Did you see the article. It focused mainly on the value.
http://psinvestor.com/weyl-weyland-tech-exposes-achilles-heel-of-unenforced-naked-short-positions/
the company is really worth a lot.
Notice the latest press release 30 min ago. The firms have to have an accounting of who owns what on the record date. They must settle all IOU's. These brokerages are not wanting to do it but will be in violation of the SEC if they do not.
This is the last hurray of the short. The manipulation is blatant but what we are waiting on is for the brokers to wake up and realize there is a problem here.
I called TD Ameritrade and you need to call the Reorg Division. DO NOT TALK to CUSTOMER SERVICE. Have them read the instructions and put it in writing that they are going to give you credit for the dividend.
Anyone call ETrade - love to compare notes. it was a 1 hour hold for me with TD ameritrade.
thats incorrect. I am the phone with TD ameritrade right now. They don't know about it. So I am having to educate them. Once educated they are going to go holy -----! That is when it happens.
Kinda was a fail. Do ppl realize 5 million shares need to trade tomorrow. 5 million of buying what is that going to do the stock price. The real question is which brokerage firm is going to get a headstart and start the buy-in now. while cheap.
This article nailed what is going on behind the scenes. WOW.
http://psinvestor.com/weyl-weyland-tech-exposes-achilles-heel-of-unenforced-naked-short-positions/
Big Buyer underneath the market. Looks like he had 100K to buy. Look at the v shaped bottom. I mean who dumps 50K shares like that. A short? That was a desperation move 1 day prior to covering. About 5 mil shares need to be bought back is my opinion. Anyone else have a tally?
Bear Raid Alert! That's all that was. They tried to scare ppl out of shares. not sure it worked. What amazing is that hongkongkingkong hasnt said anything. He was called out on that article big time.
the only news we care about now is seeing these shorts cover.
Intense article. These shorts are going to get fried.
GALT UPGRADED! They got one from Seaport and one from HC Wainwright
https://sgsecurities.bluematrix.com/sellside/EmailDocViewer?encrypt=428e4606-b6cb-4b5f-bd67-77ff47073687&mime=pdf&co=ghsecurities&id=VBernardino@seaportglobal.com&source=mail
Adam Feuerstein destroyed in article - must see for GERN fans
https://emerginggrowth.com/galectin-therapeutics-inc-nasdaq-galt-most-feared-biotech-analyst-losing-relevance-as-investors-crave-substance-over-cyber-bullying/
Looks like Feuerstein taken to woodshed in article
https://emerginggrowth.com/galectin-therapeutics-inc-nasdaq-galt-most-feared-biotech-analyst-losing-relevance-as-investors-crave-substance-over-cyber-bullying/
Adam Fuerstein slammed in article must read for NWBO stockholders
https://emerginggrowth.com/galectin-therapeutics-inc-nasdaq-galt-most-feared-biotech-analyst-losing-relevance-as-investors-crave-substance-over-cyber-bullying/
Any one see this article - seems like a lot is happening
https://emerginggrowth.com/true-nature-otcqb-tnty-sheds-its-fur-predicts-pet-biz-will-mirror-growth-of-human-health-applications/
This stock is so primed to go. I think tomorrow might be lift off.
Anyone see this blog posting - very in depth
https://seekingalpha.com/instablog/19785151-michael-sheikh/5213282-handicapping-upcoming-providence-cancer-data-melanoma
might be moving the market
Seller is finished - time to rise like a Phoenix
The CC was good and Pestell was phenomenal. He has the swagger to get us a good deal and hes well versed in business. This guy is the whole package.
I see a contradiction from you. We both agree that this prognostic test is worth a lot and if it is they can license it and make a lot of money to fund more trials. There has to be some sort of upfront payment. It seemed like there was a suitor in the works and once the acquisition is completed he will complete the licensing deal. So if you feel strong about licensing then you shouldnt feel so strong that they will do more dilutive deals.
you can listen but this was a really good recap
https://emerginggrowth.com/cytodyn-inc-otcqb-cydy-why-you-need-to-look-at-this-emerging-growth-biotechnology-company-now/
Those shares are restricted and as such CANNOT be sold for 6 months. That buys us 6 months which is plenty of time for a license deal or even a milestone.
Forget about that article did u see this one?
https://emerginggrowth.com/cytodyn-inc-otcqb-cydy-why-you-need-to-look-at-this-emerging-growth-biotechnology-company-now/
yep .70 is the resistance and then .75 - .80 because warrant overhang but dont you think something big is in the works? Too much licensing talk on the CC. Smoke = fire.
Very powerful summary - no brainer to buy here.
I know you guys seem to be swinging for the fences but baby steps. Look they said with biovid right now the combination therapy is 1.2 billion and there is a 90% likelihood of approval in the next 9 months. It seems we are trading at a discount. What do you think? they did the math for us.
Yep I think you might be right, but it doesnt matter. It seems very accurate which mean this is so undervalued.
New Article on CYDY - looks like a great recap of the conference call.
https://emerginggrowth.com/cytodyn-inc-otcqb-cydy-why-you-need-to-look-at-this-emerging-growth-biotechnology-company-now/
Stop listening and start looking. Go to the company website and scroll down and look at the cancer slides. There is new stuff in the presentation that is extremely compelling.
They aren't shelving anything - it depends on financing and financing is a function of how fast they close the Prostagene acquisition and how quickly they land licensing deals.
This is such a ridiculous statement. They are able to stop metastatic disease. They told you their strategy of a keytruda style MOA approach. did you not see the pictures? You reference GALT. did you see the latest SA article? Galectins are the axis of cancer and one axis is metastasis. Why do you think the CCL5 isnt also responsible for metastasis. You think cancer only has one way of metastasizing. Better to shut down two pathways instead of one.
Closing transaction 2 weeks, $20 mil Money, Cash Flow coming, Licensing deals, Non-dilutive financing, expanded approvals via MOA, prognostic testing. GILD + GILD mentions All positives
Negative 2.5 mil burn/month. CMC will cost more.
How does this not tip in favor as an extremely positive call.
It looks like you get it and I hope everyone reads your post. Instead of adding on to the trial to conform they are just doing a whole new trial to keep the data clean. That is the essence of the move.